The Effect of IoT-based Smart Exercises System in the Senior Adults: Resistance Band Training System

NCT07772713 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-19

No results posted yet for this study

Summary

Subjects are divided into two groups, (1) Control (Ctrl) and (2) Smart Exercise (SE) group. Participants in the Ctrl group are instructed to perform resistance band training twice weekly according to a paper-based exercise guide, whereas participants in the SE group are instructed to perform resistance band training twice weekly for 12 weeks using the Resistance Band Training System. The physical fitness tests and questionnaire of both groups are performed before and after the 12-week exercise program.

Conditions

  • Older Adults

Interventions

DEVICE

Smart Elastic Band App

Participants in the SE group perform resistance band training using the Resistance Band Training System twice weekly for 12 weeks, with each session lasting approximately 30 minutes. Training sessions and exercise completion are recorded by the system.

BEHAVIORAL

Paper-based Resistance Band Exercise Guide

Participants in the Ctrl group are instructed to perform resistance band training twice weekly for 12 weeks according to a paper-based exercise guide, with each session lasting approximately 30 minutes.

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Principal Investigators

  • Li-Chieh Kuo, Ph. D. · National Cheng-Kung University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-07
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07772713 on ClinicalTrials.gov